MTOR and cholangiocarcinoma: Since the PI3K/AKT/mTOR pathway is activated in HCC, activated mTOR serves as a representative marker for detecting the recovery or recurrence of liver cancer, including cholangiocarcinoma [86, 87] and hepatoblastoma [88, 89].